The Sleep Condition Indicator (SCI) is an eight-item rating scale that was developed to screen for insomnia disorder based on DSM-5 criteria. It has been shown previously to have good psychometric properties among several language translations. We developed age-and sex-referenced values for the SCI to assist the evaluation of insomnia in everyday clinical practice. A random sample of 200 000 individuals (58% women, mean age: 31 AE 13 years) was selected from those who had completed the SCI via several internet platforms. Descriptive and inferential methods were applied to generate reference data and indices of reliable change for the SCI for men and women across the age deciles 16-25, 26-35, 36-45, 46-55, 56-65 and 66-75 years. The mean SCI score for the full sample was 14.97 AE 5.93. Overall, women scored worse than men (14.29 AE 5.83 versus 15.90 AE 5.94; mean difference: À1.60, g 2 = 0.018, Cohen's d = 0.272) and those of older age scored worse than those younger (À0.057 points per year, 95% confidence interval (CI): À0.059 to À0.055) relative to age 16-25 years. The Reliable Change Index was established at seven scale points. In conclusion, the SCI is a useful instrument for clinicians and researchers that can help them to screen for insomnia, compare completers to individuals of similar age and sex and establish whether a reliable change was achieved following treatment.
SUMMARY
The Sleep Condition Indicator (SCI) is an eight-item rating scale that was developed to screen for insomnia disorder based on DSM-5 criteria. It has been shown previously to have good psychometric properties among several language translations. We developed age-and sex-referenced values for the SCI to assist the evaluation of insomnia in everyday clinical practice. A random sample of 200 000 individuals (58% women, mean age: 31 AE 13 years) was selected from those who had completed the SCI via several internet platforms. Descriptive and inferential methods were applied to generate reference data and indices of reliable change for the SCI for men and women across the age deciles 16-25, 26-35, 36-45, 46-55, 56-65 and 66-75 years. The mean SCI score for the full sample was 14.97 AE 5.93. Overall, women scored worse than men (14.29 AE 5.83 versus 15.90 AE 5.94; mean difference: À1.60, g 2 = 0.018, Cohen's d = 0.272) and those of older age scored worse than those younger (À0.057 points per year, 95% confidence interval (CI): À0.059 to À0.055) relative to age 16-25 years. The Reliable Change Index was established at seven scale points. In conclusion, the SCI is a useful instrument for clinicians and researchers that can help them to screen for insomnia, compare completers to individuals of similar age and sex and establish whether a reliable change was achieved following treatment.
IN TROD UCTI ON
Insomnia is the most ubiquitous of all mental health complaints in men and women of all ages and throughout ethnic groups (Singleton et al., 2001) . Insomnia is also the most prevalent of the classifiable disorders of human sleep (Lichstein et al., 2011; Morgan, 2012) . Between 25 and 42% of the adult population has troublesome insomnia symptoms each week (Swanson et al., 2011) , and even when using conservative clinical criteria, approximately 10% of adults have clinical insomnia disorder (Morin and Benca, 2012) . It has been reported that the prevalence of insomnia is higher in women (18%) than in men (12%) (Lichstein et al., 2011) and that prevalence increases in later life, particularly after the age of 60 years (Lichstein et al., 2004; Morin et al., 2009) . This is, in part, attributable to insomnia being persistent across the lifespan (Morgan, 2012) .
The importance of recognizing insomnia as a problem in its own right has been highlighted in the DSM-5 recommendation that 'insomnia disorder' should be coded 'whenever diagnostic criteria are met whether or not there is a coexisting physical, mental or sleep disorder' (American Psychiatric Association, 2013). In addition, mounting evidence suggests that chronic insomnia constitutes a risk factor for the development of physical and mental health problems (Khan and Aouad, 2017; Pigeon et al., 2017) . Similarly, insomnia is predictive of work disability (Sivertsen et al., 2006) , poorer quality of life (Kyle et al., 2010) and higher societal costs (Leger and Bayon, 2010) . Despite these facts, insomnia is seldom assessed adequately and, perhaps as one consequence, treatment services remain poor (Espie et al., 2014a; Falloon et al., 2011; Morin and Benca, 2012) .
In clinical settings, the general practitioner (GP) is typically the first point of contact. However, GPs are often short of time and may not know how to best evaluate a sleep complaint (Dyas et al., 2010) . One German study suggests that GPs are aware of a patient's sleep problem in only 9% of mild insomnia cases, 22% of moderate insomnia cases and 39% of severe insomnia cases (Hohagen et al., 1993) . A more recent Norwegian study suggests that fewer than 8% of doctors assessed sleep problems with sleep questionnaires or sleep diaries (Sivertsen et al., 2010) , even though these are recommended assessment tools to diagnose insomnia (Schutte-Rodin et al., 2008) . The positive predictive value of clinicians' evaluations of patients sleep disturbance (i.e. the probability that subjects clinically diagnosed truly have insomnia disorder) has been reported to be as low as 53% (Kallestad et al., 2011) . Qualitative studies have found that GPs wanted more training and tools to assess and manage insomnia better (Davy et al., 2015; Dyas et al., 2010) .
Given this context of a common problem that is poorly managed, brief measures that can screen for insomnia are of considerable potential clinical utility, and perhaps even more so if they are norm-referenced (Anastasi and Urbina, 1997) for the sex and age of the presenting patient. Referent data provide the clinician with specific information on whether their patient is experiencing a problem that is similar to or worse than their peer group. In addition, defining the magnitude of change that would represent reliable improvement for that population (Bland and Altman, 2003; Jacobson and Truax, 1991) may help clinicians and researchers to interpret whether treatment is successful. Such information is complementary to the use of generic 'cut-off' scores that indicate whether or not a patient meets criteria for a given disorder. We suggest that the availability of referent data might promote more informed discussion between the clinician and the patient of the problem at initial presentation, as well as assist the evaluation of outcome associated with any subsequent sleep intervention. Moreover, references can serve as a comparison group for research purposes.
In this paper, we will first assess the psychometric properties of the Sleep Condition Indicator (SCI) to confirm the SCI as a suitable instrument in a large self-referred population of 200 000 people. The SCI is a brief, eight-item scale, first published in 2014 and the first questionnaire to be modelled upon DSM-5 insomnia criteria (SCI: Espie et al., 2014b) . The SCI has subsequently been translated, and validated further in Italian, Romanian, Chinese and French (Bayard et al., 2017; Palagini et al., 2015; Voinescu and Szentagotai, 2013; Wong et al., 2017) . The SCI has demonstrated sound psychometric properties previously, including internal consistency (published range: a = 0.71-0.89), convergent validity with the Pittsburgh Sleep Quality Index (r = 0.73) and the Insomnia Severity Index (r = 0.79), predictive validity in relation to insomnia disorder when diagnosed by expert clinical interview (Bayard et al., 2017; Palagini et al., 2015; Wong et al., 2017) and has proved sensitive to change in several clinical trials (Barnes et al., 2017; Bostock et al., 2016; Espie et al., 2012; McGrath et al., 2017) . Secondly, we will present sex-and age-referent data on a sample of 200 000 people to facilitate the use in clinical and research settings. Lastly, to facilitate the use of the SCI as an outcome measure, we report data on the Reliable Change Index (RCI) (Bland and Altman, 2003; Jacobson and Truax, 1991) to facilitate the determination of meaningful changes following treatment.
METH ODS Sample characteristics
A sample of 200 000 individuals who completed the SCI online and on whom we had information concerning sex and age was extracted randomly from three platforms, namely: www.sleepio.com, which is an online (web/mobile) cognitive behavioural therapy (CBT) program for people with persistent insomnia; www.greatbritishsleepsurvey.com (GBSS), which is an online survey instrument and research tool, targeted towards UK completers; and www.worldsleepsurvey.com (WSS), which is very similar to the GBSS but with greater international exposure. It is important to recognize that participants did not comprise a true general population sample. Rather, they were likely to already have some concern about their sleep, especially those enrolling for the Sleepio program, or at least to have sufficient curiosity about their sleep to complete the online GBSS or WSS surveys. By completing the measures online, participants agreed that their data could be used anonymously for research, as specified in terms and conditions statements for each of the platforms on their respective websites. As the current evaluation was not designed formally as a research study, no additional ethical approval was obtained.
Measurements
The SCI is an eight-item scale, comprising two quantitative items on sleep continuity (item 1: getting to sleep; item 2: remaining asleep), two qualitative items on sleep satisfaction/ dissatisfaction (item 4: sleep quality; item 7: troubled or not), two quantitative items on severity (item 3: nights per week; item 8: duration of problem) and two qualitative items on attributed daytime consequences of poor sleep [item 5: effects on mood, energy or relationships (personal functioning)]; item 6: effects on concentration, productivity, or ability to stay awake (daytime performance). Validated quantitative criteria indicative of insomnia disorder (e.g. 31-45 min to fall asleep) serve as responses for sleep continuity items 1 and 2. Items 5 and 6 on daytime effects were derived by principal components analysis, as described in the initial validation report (Espie et al., 2014b) . The SCI is presented in Table 1 .
As can be seen, each item is scored on a five-point scale (0-4), with lower scores in the 0-2 range, reflecting putative DSM-5 threshold criteria for insomnia disorder (shaded area in Table 1 interpretation for clinicians and patients, total scores can be converted to a 0-10 scale by dividing the total by 3.2, where 10 represents the best possible sleep. In this paper, however, we concentrate on reporting the scale in the 0-32-point format.
A minimal additional data set was extracted comprising birth-year from which age could be estimated, and sex, in order to create age-and sex-referenced values for the SCI.
Analyses
Analysis was performed on IPython (Perez et al., 2011) and Jupyter Notebooks (Kluyver et al., 2016) , using Python version 2.7 (Python Software Foundation) and the python libraries numpy (Van Der Walt et al., 2011) and pandas (McKinney, 2010) . The means of sex and age were compared via two-sided t-tests using the scipy library (Van Der Walt et al., 2011); due to our large sample size, we report on effect size for the tests using Cohen's d and g 2 , instead of the associated t-statistic and P-value. Test-retest reliability was assessed via Pearson's r and the intraclass correlation coefficient (ICC). The regression modelling of SCI score versus age and sex was performed via a Bayesian generalized linear model using the pymc3 library (Salvatier et al., 2016) ; age and sex were modelled as continuous and categorical variables, respectively; parameters were estimated using automatic differentiation variational inference (Kucukelbir et al., 2016) and the No-U-Turn sampler (Hoffman and Gelman, 2014) . Plots were produced using the matplotlib library (Hunter, 2007) .
RESULTS

Sample characteristics
A sample of 200 000 adults who had completed the SCI online was extracted, comprising n = 116 185 females (58.0%) and n = 83 815 males (42.0%). The mean age of the total sample was 31 AE 13 years, with females being on average 30 AE 13 years and males 32 AE 12 years. Six agegroup subsamples-16-25 years (n = 87 576), 26-35 years (n = 52 135), 36-45 years (n = 29 253), 46-55 years (n = 18 109), 56-65 years (n = 9876) and 66-75 years (n = 3051)-were also derived. Because the data are extracted from commercially used platforms we were not able to use the full sample for these analyses; however, the sample was representative of the larger population with a similar distribution of age (mean: 31 AE 13 years, difference with sample mean: 0.003, g 2 = 0.001, P = 0.94) and gender (58.0% females and 42.0% males). Differences in SCI between the full population and the sample for each of the gender-age subgroups were assessed via t-tests and found to be negligible (absolute difference in means for all groups <0.02, g 2 for all groups <0.001, P for all groups >0.88].
Psychometric properties of SCI
As can be seen in Fig 1, SCI data formed a slightly rightskewed distribution with a mean value of 14.97 (FisherPearson coefficient of skewness: 0.283). Psychometric properties can be found in Table 2 . I don't have a problem/< 1 month 1-2 months 3-6 months 7-12 months > 1 year Scoring instructions: Add the item scores to obtain the SCI total (minimum 0, maximum 32); a higher score means better sleep. Scores can be converted to 0-10 format (minimum 0, maximum 10) by dividing total by 3.2 to facilitate interpretation.; Item scores in grey area represent threshold criteria for DSM-5 Insomnia Disorder.
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Internal consistency
Cronbach's a for the entire sample was acceptable at 0.733 (range of a-if-item-deleted: 0.671-0.744). Mean corrected item-total correlation was moderate (r = 0.454), indicating substantial unique variance per item (6-41.6%, with shared variance = 20.6%). Table S1 summarizes data on these parameters by sex and age group, from which it can be seen that internal consistency is uniformly acceptable (range: a = 0.704-0.775) and the mean item-total correlation ranges from r = 0.424 to 0.505.
Test-retest reliability
In order to estimate test-retest reliability, we identified a small sample of SCI completions (n = 180, 71% females, mean age 44 AE 14 years) by the same user within an interval of no less than 12 h and no greater than 7 days. The resulting test-retest reliability and intraclass correlation coefficients were r = 0.84 and ICC = 0.84, respectively.
Reference values for the SCI
Mean score on the SCI for the whole sample was 14.97 AE 5.93. Fig 2 and Visual inspection of Fig 2 illustrates that progressively poorer sleep with increasing age was the norm for both men and women. We investigated this relation by performing a linear regression of SCI versus age and gender. Our results are consistent with a decrease in the total SCI of À0.057 points per year [95% confidence interval (CI): À0.059 to À0.055] relative to baseline age. Fig. S1 depicts distribution curves of SCI scores by sex and age. Table 3 provides a summary of SCI descriptives; interquartile ranges may be useful to assess at which quartile a patient scores. Fig S1 can be used to assess where a given patient fits within the overall distribution of scores at a particular stage in life.
RCI for the SCI
Rather than relying on an anchor-based approach, we followed Jacobson and Truax's (1991) RCI and Bland and Altman (2003) approach to determine a reliable unit of change, representing 95% of the standard error of the mean (SEM). Utilizing our full SCI distribution data set, and taking into account our observed test-retest coefficient we arrived at a mean RCI: 6.54. This RCI appears stable throughout the age-groups (see Table S1 ) for both women (RCI range: 6.07-6.64) and men (RCI range: 6.24-6.82).
Given that the SCI is always scored in whole integers, we suggest that RCI = 7 is the most parsimonious value for use in clinical and research practice, and that it is applicable for men and women of all ages.
It should be noted, however, that item 8 ('how long have you had a problem with your sleep') could be omitted from some calculations of change, because duration of sleep problems, while relevant for screening and diagnosis, is not necessarily appropriate for measuring change. Therefore, we also calculated the RCI for the SCI omitting item 8. For the remaining seven SCI items we calculated mean RCI = 5.79, and again the RCI appeared stable throughout the age groups (see Fig S1) , both for women (range of RCI: 5.39-6.16) and men (RCI range: 5.39-6.22). Consequently, we recommend that when the SCI is used in seven-item format for pre-post evaluation, RCI = 6 is the most suitable index value.
Previous research has supported the use of a cut-off of 16 for possible insomnia disorder (Ballesio et al., 2017; Bayard et al., 2017; Espie et al., 2014b; Palagini et al., 2015; Wong et al., 2017) . In the present sample we applied criteria based on the DSM-5 to our data set to distinguish those with possible insomnia from 'normal' sleepers. Criteria included were (a) difficulty initiating or maintaining sleep: SCI item 1 or SCI item 2 above 30 min and SCI item 4 'average' or worse; (b) significant distress: SCI item 7 'somewhat' or worse and SCI item 5 or SCI item 6 'somewhat' or worse; (c) frequency: SCI item 3 equal to or above 3 nights per week; and (d) duration: SCI item 8 equal to or above 3 months. This created two distributions, one of 'normal' sleepers (n = 93 293, 54% female, mean age: 29.78 AE 12.23 years and one of those with possible insomnia (n = 106 707, 61% female, mean age: 32.59 AE 13.12 ears. As can be seen in Fig S2, the difference between these groups exceeds the RCI of 6.5 points, providing further support for the RCI.
DISCUSSION
The SCI was developed as a brief, DSM-5 compliant screening tool to assist in the population and clinical evaluation of insomnia, and this study confirms previous reports that the SCI has sound psychometric properties across the adult age range. Indeed, it was the availability of a very large data set of this brief measure that led us to evaluate the properties of the SCI by sex and age group.
Such referent data provide the individual and the clinician with useful information on whether a presenting problem is similar to or worse than that of the comparator peer group. This is how we suggest that the data tables and figures, including in the Supporting information, may be useful in practice. The SCI score can also be completed and compared to the current reference values via the www.slee pio.com/sleep-condition-indicator. It is both interesting and important to compare scores in any clinical domain with 'norms', but often reference values reported in the insomnia literature are not detailed in relation to such characteristics, and the validation samples are relatively small. These SCI data permit consideration of how an individual is sleeping, not just in relation to a clinical cut-off, but also in relation to large samples of other people of their sex and age. The results demonstrate, for example, that women's sleep is generally poorer than men's; women score consistently at least 2 SCI scale points lower than men from the 36-45-year range upwards. In addition, progressively poorer sleep with increasing age is the norm for both men and women.
With regard to treatment effects, our results suggest that the magnitude of change that would represent reliable improvement on the SCI is 7 scale points; when all eight items of the SCI are included, a change of 6 scale points is needed to indicate reliable improvement when the duration item (item 8) is excluded of the SCI. This value (RCI = 7) seems appropriate for men and women across the age deciles although, again, variability can be interrogated from the tables. At the clinical level (or in research), therefore, improvement for a given patient may be interpreted in several ways using the SCI. A change in status may be inferred from: (a) an SCI score reduction from below the clinical cut-off of 16 to a score that is now above that cut-off; or (b) by a reliable change increase in SCI score of 7 points or greater.
There are important limitations that need to be taken into account. In particular, the data presented here are not true population norm-referenced values. What these data represent is simply a randomly selected convenience sample of people who had completed the SCI online. Thus, although the sample is large, it is not representative of the general population. We did not sample based upon sex and age demographics. It is evident, for example, that younger age ª 2017 European Sleep Research Society groups are considerably over-represented. Moreover, we do not have information on other population characteristics, such as socioeconomic or civil status, which one would expect to find using normative sampling methods. Also, there is a sampling bias in favour of those who have an interest in sleep by virtue of their self-selection to complete an online test and a bias towards those with a sleep problem. For example, more than half the sample screened positive for possible insomnia. In addition, we were unable to analyse the full pool of data that formed the base of the extracted sample of 200 000. Commercial platforms were used to extract the data; usage numbers, such as a total N, are viewed typically as commercially sensitive. Our extracted sample was, however, representative of the full pool of data.
The limitations mentioned above are likely to have some effect on the reliability of the reference values themselves, and further research is required to confirm their representative nature. Conversely, the RCI may be more robust because the clinical population was, in fact, over-represented. There is also need for further validation of the SCI when used routinely in primary care looking at feasibility of use, acceptability and comparison with other insomnia measures. Lastly, with regard to the psychometrics, we were only able to test the test-retest reliability in a small sample that might not necessarily be representable of the larger sample. Unfortunately, we do not have any in-depth knowledge on why people completed the SCI more than once and how this influenced the representability of this sample; on all platforms the SCI can be taken multiple times without stating any reasons. With regard to the internal consistency of the SCI, it is important to keep in mind that the SCI is created to follow DSM-5 criteria for insomnia disorder, hence measuring a variety of constructs such as sleep onset latency but also daytime effects. This may make the internal consistency values less conceptually meaningful for the SCI then traditional questionnaires. However, one could argue equally that because of the variable nature of the response format of the items in the SCI, the internal consistency range of 0.70-0.78 is therefore better than to be expected.
CONCLUSI ON
The SCI is a reliable, simple and valid tool for potential wider use in general practice and secondary care settings. It can be used routinely for screening of insomnia, to assist diagnosis and for the clinical (and/or self-) monitoring of treatmentrelated change. An SCI improvement of seven points represents reliable change. The availability of sex-and age-referenced values adds to the practical utility at the clinical interface as well as strengthening credentials as a research tool.
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